US stock · Healthcare sector · Pharmaceutical Retailers
Company Logo

Walgreens Boots Alliance, Inc.

WBANASDAQ

32.43

USD
-0.26
(-0.80%)
Market Closed
5.50P/E
7Forward P/E
0.27P/E to S&P500
28.028BMarket CAP
5.84%Div Yield
Upcoming Earnings
13 Oct
Shares Short
8/31/22
27.18M
Short % of Float
3.79%
Short % of Shares Outs.
3.14%
% Held by Insiders
17.32%
% Held by Institutions
59.61%
Beta
0.62
PEG Ratio
7.41
52w. high/low
55.00/32.33
Avg. Daily Volume
6.80M
Return %
Stock
S&P 500
1 year
(33.15)
(16.78)
3 years
(40.32)
22.95
5 years
(58.19)
45.49
Scale: |
High
Low
49.10
35.80
39.00
21.28
40.69
21.39
40.20
26.26
47.11
30.34
37.75
28.53
60.93
37.06
77.98
55.27
97.30
73.00
88.00
71.50
89.69
63.82
86.31
59.07
74.94
49.03
59.78
33.36
57.05
39.94
55.00
32.33
Currency: USD
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
TTM
Revenue per share
46.93
53.84
59.59
63.97
68.68
78.88
81.89
76.34
80.15
99.16
108.35
110.12
132.73
148.53
158.67
153.23
155.58
Earnings per share
1.73
2.04
2.18
2.03
2.13
2.97
2.43
2.59
2.03
4.05
3.85
3.80
5.07
4.32
0.52
2.94
6.20
FCF per share
1.09
0.57
0.82
2.21
2.78
2.66
3.29
3.27
2.92
4.23
6.02
5.50
6.96
4.22
4.67
4.83
3.72
Dividends per share
0.26
0.31
0.38
0.45
0.55
0.71
0.90
1.10
1.26
1.33
1.44
1.61
1.75
1.78
1.99
1.87
1.92
CAPEX per share
1.32
1.79
2.25
1.95
1.03
1.33
1.77
1.28
1.16
1.20
1.22
1.26
1.38
1.85
1.56
1.59
1.96
Book Value per sh.
10.01
11.12
12.99
14.52
14.67
16.22
20.85
20.56
21.46
29.58
27.59
25.59
26.24
25.51
23.47
27.08
30.87
Comm.Shares outs.
1,010
999
991
990
982
915
875
946
953
1,043
1,083
1,074
991
922
879
865
865
Avg. annual P/E ratio
25.5
21.4
15.1
15.6
15.7
13.1
14.0
19.0
32.7
21.0
21.0
20.9
13.9
13.6
82.5
17.0
5.5
P/E to S&P500
1.4
1.2
0.7
0.2
0.8
0.8
0.9
1.1
1.8
1.0
0.9
0.9
0.6
0.6
2.2
0.6
0.3
Avg. annual div. yield
0.6%
0.7%
1.2%
1.4%
1.6%
1.8%
2.6%
2.2%
1.9%
1.6%
1.8%
2.0%
2.5%
3.0%
4.6%
3.7%
4.4%
Revenue (m)
47,409
53,762
59,034
63,335
67,420
72,184
71,633
72,217
76,392
103,444
117,351
118,214
131,537
136,866
139,537
132,509
134,516
Operating margin
5.7%
5.9%
5.8%
5.1%
5.1%
6.0%
4.8%
5.5%
5.5%
4.5%
5.1%
4.7%
4.9%
3.7%
0.9%
1.8%
2.3%
Depreciation (m)
572
676
840
975
1,030
1,086
1,166
1,283
1,316
1,742
1,718
1,654
1,770
2,038
1,927
1,973
2,020
Net profit (m)
1,751
2,041
2,157
2,006
2,091
2,714
2,127
2,450
1,932
4,220
4,173
4,078
5,024
3,982
456
2,542
5,379
Income tax rate
36.4%
36.0%
37.1%
36.6%
38.0%
36.8%
37.0%
37.1%
42.9%
19.9%
19.4%
15.7%
16.7%
13.0%
48.5%
33.4%
(313.6)%
Net profit margin
3.7%
3.8%
3.7%
3.2%
3.1%
3.8%
3.0%
3.4%
2.5%
4.1%
3.6%
3.4%
3.8%
2.9%
0.3%
1.9%
4.0%
Working capital (m)
3,950
2,766
3,790
5,280
4,489
4,239
2,038
2,991
3,347
3,100
8,870
1,206
(3,821)
(7,069)
(8,997)
(6,240)
(5,195)
Long-term debt (m)
- -
- -
1,337
2,336
2,389
2,396
4,073
4,477
3,736
13,315
18,705
12,684
12,431
11,098
12,203
29,828
32,220
Equity (m)
10,116
11,104
12,869
14,376
14,400
14,847
18,236
19,454
20,457
30,861
29,880
27,466
26,007
23,512
20,637
23,419
30,382
ROIC
15.4%
16.2%
13.7%
11.2%
11.4%
14.2%
8.8%
9.6%
7.3%
9.1%
8.4%
10.0%
12.1%
11.1%
1.3%
4.7%
42.4%
Return on capital
16.1%
16.5%
15.3%
12.9%
13.2%
15.9%
10.4%
11.4%
9.7%
8.6%
8.0%
8.5%
9.8%
7.9%
1.7%
5.1%
7.6%
Return on equity
17.3%
18.4%
16.8%
14.0%
14.5%
18.3%
11.7%
12.6%
9.4%
13.7%
14.0%
14.8%
19.3%
16.9%
2.2%
10.9%
17.7%
Plowback ratio
85.0%
84.8%
82.6%
77.8%
74.1%
76.2%
63.0%
57.6%
37.9%
67.2%
62.5%
57.7%
65.4%
58.7%
(283.1)%
36.4%
79.4%
Div.&Repurch./FCF
55.6%
193.8%
56.5%
33.2%
84.1%
110.1%
68.7%
53.6%
68.3%
59.1%
41.6%
117.7%
101.0%
149.1%
81.2%
41.4%
57.5%
Capital Structure
30 Jun · 2022 | Q3
All numbers in millions
Total liabilities
$ 62,377
Total assets
$ 92,759
Long-term debt
$ 32,220
Cash and equiv.
$ 2,285
Goodwill
$ 21,901
Retained earnings
$ 39,046
Common stock
864
Enterprise Value
$ 57,963
Working Capital
Currency: USD, in millions
2019
2020
2021
Cash & Investments
1,023
516
1,193
Receivables
7,226
7,132
5,663
Inventory
9,333
9,451
8,159
Other
1,118
467
969
Current assets
18,700
18,073
15,814
Acc. Payable
14,341
14,458
11,136
Debt due
5,738
5,965
3,565
Other
5,690
6,647
7,353
Current liabilities
25,769
27,070
22,054
Annual growth rates
(avg. rate of change)
1 year
5 years
10 years
Revenue
(5.04)%
3.06%
7.60%
Cash flow
1.61%
(4.86)%
8.29%
Earnings
457.46%
92.84%
53.38%
Dividends
(7.44)%
(1.43)%
8.93%
Book value
13.48%
(3.41)%
4.20%
Insider Trading
Type
Shares
Date
Jarrett Valerie B
Award
671
07/13/22
Lederer John Anthony
Award
671
07/13/22
Murphy Dominic
Award
671
07/13/22
Brailer David J
Award
806
07/13/22
Kehoe James
InKind
5,733
05/01/22
Quarterly Revenue
Currency: USD, in millions
Year
1Q
2Q
3Q
4Q
Total
2020
34,339
35,820
34,631
34,746
139,536
2021
36,307
32,779
34,030
34,262
137,378
2022
33,901
33,756
32,597
- -
- -
Earnings per share
Currency: USD
Year
1Q
2Q
3Q
4Q
Total
2020
0.96
1.08
(1.94)
0.42
0.52
2021
(0.36)
1.19
1.38
0.73
2.94
2022
4.13
1.02
0.33
- -
- -
Quarterly dividends paid
Currency: USD
Year
1Q
2Q
3Q
4Q
Total
2020
0.47
0.51
0.46
0.55
1.99
2021
0.47
0.47
0.47
0.47
1.87
2022
0.48
0.49
0.48
0.48
1.92
Company Description
Sector:
Healthcare
Industry:
Pharmaceutical Retailers
CEO:
Mr. Stefano Pessina
Full-time employees:
315,000
City:
Deerfield
Address:
108 Wilmot Rd
IPO:
Dec 31, 2014
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides central specialty pharmacy services and mail services. As of August 31, 2021, this segment operated 8,965 retail stores under the Walgreens and Duane Reade brands in the United States; and five specialty pharmacies. The International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty retail stores and optical practices, as well as through boots.com and an integrated mobile application. It also engages in pharmaceutical wholesaling and distribution business in Germany. As of August 31, 2021, this segment operated 4,031 retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile; and 548 optical practices, including 160 on a franchise basis. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.
Recent News
· 20 Sep, 2022 · The Wall Street Journal
· 11 Aug, 2022 · The Wall Street Journal
· 10 Aug, 2022 · The Wall Street Journal
· 8 Jul, 2022 · The Wall Street Journal
· 30 Jun, 2022 · The Wall Street Journal
· 4 May, 2022 · The Wall Street Journal
· 27 Apr, 2022 · The Wall Street Journal
· 6 Jan, 2022 · The Wall Street Journal
· 14 Oct, 2021 · The Wall Street Journal
· 14 Oct, 2021 · The Wall Street Journal
· 24 Sep, 2021 · The Wall Street Journal
· 15 Sep, 2021 · The Wall Street Journal
· 27 Jan, 2021 · The Wall Street Journal
· 6 Jan, 2021 · The Wall Street Journal